9-month, MDR-TB treatment in HIV & non-HIV co-infected patients in Swaziland & Uzbekistan
Channel: F1000
Date: 2015-06-10

Esther Casas, MSF, demonstrates the interim outcomes of two prospective studies looking at treatment with a short course regimen for multidrug resistant TB (MDR TB) in two settings; Uzbekistan and Swaziland. The main conclusions that can be drawn from this are that we need shorter, safer and more tolerable regimens to treat MDR TB. Outcomes indicate that early culture conversion to new treatment methods seems positive, but as expected there are some failures.

Slides are available to download here: http://f1000research.com/slides/1000085.

This video is part of an F1000Research channel that includes posters, slides and videos from the MSF Scientific Day meetings in the UK and India. To see more please visit: http://f1000research.com/msf/sciday-uk15.